Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Target Price at $35.22

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Free Report) have received an average recommendation of “Moderate Buy” from the eleven brokerages that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $34.44.

Several analysts have recently commented on the stock. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Needham & Company LLC reduced their price objective on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research note on Friday, May 3rd. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $35.00 to $28.00 and set an “outperform” rating for the company in a research note on Tuesday, June 25th. Finally, Piper Sandler reiterated a “neutral” rating and issued a $32.00 price objective (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd.

Check Out Our Latest Stock Analysis on DENTSPLY SIRONA

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 3,577 shares of the company’s stock in a transaction on Friday, May 31st. The stock was purchased at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the acquisition, the director now owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.52% of the stock is currently owned by insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently modified their holdings of the company. VisionPoint Advisory Group LLC grew its holdings in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 395 shares in the last quarter. Principal Securities Inc. purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth about $26,000. Headlands Technologies LLC purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth about $30,000. Parkside Financial Bank & Trust grew its holdings in shares of DENTSPLY SIRONA by 33.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after buying an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth about $47,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Trading Down 1.5 %

XRAY stock opened at $24.91 on Monday. DENTSPLY SIRONA has a one year low of $24.71 and a one year high of $41.65. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. The company has a fifty day moving average of $27.72 and a 200-day moving average of $31.71.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. During the same quarter last year, the business earned $0.39 EPS. The business’s revenue was down 2.6% on a year-over-year basis. Research analysts forecast that DENTSPLY SIRONA will post 2.02 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, June 28th. This represents a $0.64 annualized dividend and a yield of 2.57%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

About DENTSPLY SIRONA

(Get Free Report

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.